body 2." For example, anti-I-A' x anti-HEL refers to a gel filtration fraction of 300 kD or greater, obtained when anti-I-A' was crosslinked to anti-HEL. Antibodies used in this paper are anti-HEL, HyHEL-8 (9) ; anti-I-Ak, 10-2.16 (10); anti-I-Ad, MKD6 (11) ; anti-KkDd, 34.1.2 (12) ; anti-Kk, 36.7.5 (12) ; anti-Fc y RII, 2AG2 (13) ; anti-IgDa, AM628.1 (14) ; and anti-IgD', AF3-33.3 (14) . Fab fragments were produced by papain digestion and were purified by gel filtration followed by ion exchange chromatography (15) .
Results and Discussion
Female A/J mice were given subcutaneous injections of graded amounts of HEL or HEL mixed with HBAs, on day 0. 21 d later, the mice were bled to determine serum anti-HEL IgG antibody levels . On day 22, the mice were given booster injections of 5 ttg ofHEL per hind foot pad, to induce secondary IgG antibody responses . Sera were collected 11 d later and IgG antibody was measured. Fig. 1 shows that >10 Ag of HEL per mouse was required in a primary injection to produce either a primary or a secondary IgG antibody response, if the HEL was given alone. However, in the presence of 10 Wg of HBA (anti-I-A' x anti-HEL), 100 ng of HEL induced a substantial primary IgG antibody response, and as little as 10 ng of HEL induced a strong secondary response. In other experiments (e.g., Fig . 2 ), <1 ng of HEL in the presence of HBA gave a significant secondary response. Mice receiving PBS as a primary injection, and then given a secondary challenge of HEL ( Fig.  1) , or given the HBA alone as a primary injection and then a secondary challenge of HEL (Fig. 2) , produced little or no IgG antibody. We compared immunization using HBAs with that of HEL emulsified in IFA (Fig. 2) . The two types of immunization produced similar amounts of IgG antibody in the secondary response, especially at low HEL doses. Thus, the HBA specific for HEL and class II MHC structures increased the efficiency of immunization by 300-fold in the primary response, and by a factor of 103 to 104 after a secondary boost. The HBA increased the efficiency of priming for secondary IgG antibody responses at least as well as IFA .
We constructed several other HBAs that could bind to different surface molecules (16) (17) (18) (19) (20) . Several important controls for the effect of HBAs are shown in Table II . First, HBAs enhanced antibody production only ifthe appropriate antibodies were in fact crosslinked; monomeric mixtures of antibodies did not work (Table II, Exp. 1). Second, antibody was induced only if the strain of mouse immunized expressed the structures to which the HBA could bind (Table II, Exp. 2). Thus, HBAs with I-Ad or KdDd specificities did not produce responses in H-2k (C3H) mice, but did produce responses in H-2k x H-2d (CAFI) mice . The same I-Ad-specific HBA did not induce antibody in A/J mice, but the KdDd-specific HBA did, since this strain expresses Dd but not I-Ad . Both the C3H and the A/J mice responded when immunized with the HEL-and Fc yRII-specific HBA.
Because antigen targeted to Fc yRII gave enhanced antibody responses to HEL in several strains, it was important to show that the HBAs were not simply forming immune complexes with HEL and binding via their Fc portions to FcYR on APC. Therefore, we constructed an HBA from Fab fragments of anti-HEL and anti-I-A k mAbs, and compared its ability to induce anti-HEL antibody with that of its intact Ig counterpart (Table II, Exp. 3). The results show that the Fab-HBA performed as well as the intact Ig-HBA over a range of dosages, indicating that the Fc regions of the HBA were not required for enhanced antibody production . This conclusion is also supported by the observation that anti-H-2d-specific HBAs did not promote antibody production in H-2k (i.e., C3H) mice (Table II, Exp. 
2) .
It is likely that HBAs increase anti-HEL production in mice by targeting HEL to surface structures on APC in vivo. Such targeting would cause the antigen to be processed and presented to T cells with much higher efficiency than antigen given alone, as documented in vitro (3) (4) (5) . Presumably, such APC could then generate large numbers of antigen-specific Th cells, which in turn would stimulate antigenspecific B cells. The known T cell dependence of anti-HEL responses in mice (21, 22) supports this view.
Our use of HBAs to enhance immunization follows on previous results (18, (23) (24) (25) , showing that antigens that were chemically crosslinked directly to antibodies specific for class II MHC or IgM molecules were more potent immunogens than antigens given alone. HBAs provide several important advantages over chemically linked antigen-antibody conjugates . First, HBAs could be used to enhance responses against small amounts ofimpure antigens, for example, tumor antigens, whereas direct linkage of antigen to antibody requires relatively large amounts ofhighly purified antigen. HBAs do not require biochemical modification of antigen, which could alter its immunogenicity. In addition, bispecific antibodies in the form of hybrid-hybridomas (26, 27) or hetero-F(ab')2 (28) can be prepared as single homogeneous species, whereas antibody-antigen chemical complexes are heterogeneous, and vary between preparations . Therefore, homogeneous bispecific antibodies would be much more suitable for large scale production than the antigen-antibody chemical complexes. Groups of female mice (4-5 per group) were injected with the indicated doses of HEL or antibody . In Exp . 1, the effect of HBAs on the anti-HEL antibody response was compared with that of the uncrosslinked fraction (mix) obtained during purification of HBAs, and to that of the anti-HEL mAb alone . In Exp . 2, the specificity of targeting was tested in mouse strains that express structures to which particular HBAs bind or do not bind . C3H/HeJ and A/J mice were also immunized with HEL plus an anti-FcyRIIspecific HBA as a control for their ability to respond to targeted HEL . The isotypes and allotypes of antibodies used in this experiment were as follows : munization would be efficient and would avoid the use of adjuvants that have unwanted inflammatory effects (29) , and cannot, therefore, be used in humans .
Summary
The binding of protein antigens to APC with heterocrosslinked bispecific antibodies (HBAs) enhances their processing and presentation to Th cells in vitro. Here we have asked whether HBAs could also increase immune responses in vivo. We immunized mice with hen egg lysozyme (HEL) in the presence or absence of HBA, and followed antibody production after the primary challenge and after a secondary boost . We found that HBAs that bind antigen to MHC class I or II molecules, to FoyR, but not to surface IgD, enhance the immunogenicity of HEL . HBAs that bound HEL to MHC class II molecules, for examples, decreased the amount of antigen required to elicit a primary anti-HEL antibody response in mice by 300-fold, and the amount required to prime for a secondary response by 103-to 10'-fold. In fact, HBAs were as effective as IFA in generating antibody responses . Since adjuvants cannot be used in humans, HBAs could prove useful for immunizing people, especially in cases where, due to scarcity or toxicity, minute doses of antigen must be used.
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